Trial intelligence / Profile preview

Paricalcitol in diabetic and non-diabetic chronic kidney disease

2007-006274-29Phase 2Completed

Sponsor
Karolinska Institutet
Start
Sep 2009
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2 trial of paricalcitol in chronic kidney disease (CKD) and diabetic glomerulosclerosis (2 cohorts), sponsored by Karolinska Institutet. Started Sep 2009; status: completed.

02

Drugs

paricalcitol
03

Conditions

chronic kidney disease (CKD)diabetic glomerulosclerosis

Beyond the preview

Go deeper on 2007-006274-29.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-006274-29.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call